Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 28.77 CNY -1%
Market Cap: 46.3B CNY
Have any thoughts about
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Wall Street analysts forecast Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 26.69 CNY with a low forecast of 18.99 CNY and a high forecast of 37.91 CNY.

Lowest Forecast
Wall Street Target
18.99 CNY
34% Downside
Average Forecast
Wall Street Target
26.69 CNY
7% Downside
Highest Forecast
Wall Street Target
37.91 CNY
32% Upside
Lowest
Price Target
18.99 CNY
34% Downside
Average
Price Target
26.69 CNY
7% Downside
Highest
Price Target
37.91 CNY
32% Upside
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors:
Price Targets
BSEM
Biostem Technologies Inc
145% Upside
PBH
Prestige Consumer Healthcare Inc
14% Upside
Z
600267
Zhejiang Hisun Pharmaceutical Co Ltd
23% Downside
CRON
Cronos Group Inc
27% Upside
BSEM
Biostem Technologies Inc
145% Upside
PBH
Prestige Consumer Healthcare Inc
14% Upside
Z
600267
Zhejiang Hisun Pharmaceutical Co Ltd
23% Downside
CRON
Cronos Group Inc
27% Upside
S
4507
Shionogi & Co Ltd
13% Upside
P
603566
Pulike Biological Engineering Inc
11% Upside
1795
Lotus Pharmaceutical Co Ltd
70% Upside
2096
Simcere Pharmaceutical Group Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 6%.

19%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 0%.

19%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 3%.

15%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's stock price target?
Price Target
26.69 CNY

According to Wall Street analysts, the average 1-year price target for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 26.69 CNY with a low forecast of 18.99 CNY and a high forecast of 37.91 CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 6%.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Operating Income forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 0%.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Net Income forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 3%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.